Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR/Src/mTOR pathway

BACKGROUND: Morphine, a µ-opioid receptor (MOR) agonist, has been shown to be related to the activity of cancer cells, and a higher morphine dosage reduces the survival time of patients with lung cancer. However, the effect of morphine on the malignant behavior of lung cancer cells remains unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xingyun, Yang, Jia, Yang, Chengwei, Huang, Xiang, Han, Mingming, Kang, Fang, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613927/
https://www.ncbi.nlm.nih.gov/pubmed/34823532
http://dx.doi.org/10.1186/s12935-021-02334-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613927/
https://www.ncbi.nlm.nih.gov/pubmed/34823532
http://dx.doi.org/10.1186/s12935-021-02334-8

Ejemplares similares